Information concerning the administration of psychotropic PRN medication in Scottish PICUs is scarce. The medical notes and prescription charts of all patients (n = 75) admitted during the study period were consulted to determine the frequency and nature of PRN practice. 65% of patients (n = 49) were administered up to 11 drugs comprising of antipsychotics (n = 8), benzodiazepines (n = 2) and zopiclone. The most frequently administered PRN medicines were lorazepam, haloperidol and zuclopenthixol. The mean dose administered for oral and intramuscular (IM) forms of both lorazepam and haloperidol were very similar. The mean number of PRN administrations per patient per day was 0.4. 40% of psychotropic PRN administrations were initiated by the nurse with the majority of doses administered at bedtime. Ten patients received an IM injection. Four patients were restrained during these administrations. Documentation pertaining to the rationale for IM administrations and of pre and post rapid tranquillisation physical health monitoring was lacking. This study highlights variation in practice between units, inadequate monitoring and documentation, a possible lack of understanding by prescribers of the differences in bioavailability between oral and injectable forms of medication and relatively limited use of newer drugs
AimTo identify if medical staff in a general paediatrics unit are correctly identifying, classifying and documenting hydration status in gastroenteritis, and to determine if appopriate investigations and treatment were used based on this status and clinical impression. With these findings, to identify ways in which management of gastroenteritis and dehydration in our unit can be improved.MethodsWe carried out a retrospective audit, with a target population of children admitted to the paediatrics ward with a working diagnosis of gastroenteritis between January and August 2016. Children included were aged 0 – 14. A criteria form was used to collect our data, and a HIPE database to identify appropriate cases. Initially we audited 130 charts, however following exclusion for a number of reasons 92 were included in the audit. We used guidelines from OLCHC in Dublin to compare our performance against.ResultsDocumentation: 31.5% of children admitted with a diagnosis of gastroenteritis did not have documentation of hydration status or clinical features regarding hydration. Only 26% had a hydration status documented.Investigations: 88% of children had blood tests taken, and 30.4% had stool cultured performed.Treatment: A large number (80%) received IV fluid rehydration, either bolus or maintenance fluids. Only 2 children were managed with Oral Rehydration Solution, and zero received NG tube rehydration. In many cases, the treatment implemented did not correlate with the hydration status or clinical impression given, and as such it was difficult to evaluate if treatment was appropriate.ConclusionsCompliance with OLCHC guidelines as present on the paediatrics ward needed improvement, in all areas including documentation, investigation and management. Documentation was often absent or minimal, and there was variation in the quality of documentation. Many patients had blood tests done where it was not felt appropriate and did not influence the management of the patient. Our results suggested a greater role for the enteral route of rehydration within the department, and that we are overusing IV fluids in most instances. Based on these conclusions, we have carried out education sessions and also plan to make changes to our admission proforma and use more updated guidelines in our management of gastroenteritis. With these changes in place we hope to re-audit in 3 months time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.